Cargando…
α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study
The incidence and prevalence of inflammatory bowel disease (IBD, Crohn's disease, and ulcerative colitis) are increasing worldwide. The etiology of IBD is multifactorial, including genetic predisposition, dysregulated immune response, microbial dysbiosis, and environmental factors. However, man...
Autores principales: | Venkataraman, Balaji, Almarzooqi, Saeeda, Raj, Vishnu, Dudeja, Pradeep K., Bhongade, Bhoomendra A., Patil, Rajesh B., Ojha, Shreesh K., Attoub, Samir, Adrian, Thomas E., Subramanya, Sandeep B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020997/ https://www.ncbi.nlm.nih.gov/pubmed/35465355 http://dx.doi.org/10.1155/2022/5498115 |
Ejemplares similares
-
Molecular Docking Identifies 1,8-Cineole (Eucalyptol) as A Novel PPARγ Agonist That Alleviates Colon Inflammation
por: Venkataraman, Balaji, et al.
Publicado: (2023) -
Nerolidol Mitigates Colonic Inflammation: An Experimental Study Using both In Vivo and In Vitro Models
por: Raj, Vishnu, et al.
Publicado: (2020) -
Thymoquinone, a Dietary Bioactive Compound, Exerts Anti-Inflammatory Effects in Colitis by Stimulating Expression of the Colonic Epithelial PPAR-γ Transcription Factor
por: Venkataraman, Balaji, et al.
Publicado: (2021) -
Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies
por: Raj, Vishnu, et al.
Publicado: (2023) -
β-Myrcene Mitigates Colon Inflammation by Inhibiting MAP Kinase and NF-κB Signaling Pathways
por: Almarzooqi, Saeeda, et al.
Publicado: (2022)